• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布氏杆菌溃疡病的外科治疗:来自加纳四个流行地区的四年经验。

Surgical management of buruli ulcer disease: a four-year experience from four endemic districts in ghana.

作者信息

Adu Ejk, Ampadu E, Acheampong D

机构信息

Department of Surgery, School of Medical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

出版信息

Ghana Med J. 2011 Mar;45(1):4-9. doi: 10.4314/gmj.v45i1.68914.

DOI:10.4314/gmj.v45i1.68914
PMID:21572818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3090092/
Abstract

BACKGROUND

Mycobacterium ulcerans (MU) disease causes extensive destruction of tissues leaving large ulcers on the body. Management which consisted of surgical excision of the lesions is gradually being replaced with chemotherapy.

OBJECTIVE

To study the impact on surgery of prior treatment of MU disease with rifampicin and streptomycin.

STUDY DESIGN

Retrospective, from September 2004 to September 2009.

SETTING

Asunafo, Amansie West, Ahafo Ano and Amansie Central districts of Ghana.

METHODS

Patients who have completed 8 weeks or a minimum of 4 weeks treatment with rifampicin and streptomycin but have unhealed lesions were selected for surgery.

RESULTS

132 patients had surgery for MU disease; 51 at Tepa (Ahafo Ano); 36 at Agroyesum (Amansie West); 16 from Jacobu (Amansie Central); 29 from Goaso (Asunafo) districts. Their ages ranged from 4 to 98 years, with mean age of 29.90 years, standard deviation of 20.74. Sites involved were: head and neck 1 (0.74%), upper limb 40 (29.63%), lower limb 92 (68.15%), trunk 2 (1.48%) (N=135). The clinical forms were: papule 1 (0.74%), nodule 2 (1.48%), oedematous lesion 4 (2.96%), osteomyelitis 2 (1.48%), ulcers 124 (91.85%), contractures 2 (1.48%). 139 surgical procedures were performed: excision 25 (18.11), skin grafting 36 (26.1%), excision and skin grafting 54 (39.1%), debridem net 10 (7.2%), sequestrectomy 2 (1.4%), regrafting 10 (7.2%), release of contractures 2 (1.4%).

CONCLUSION

Treatment of MU disease with rifampicin and streptomycin improved the condition and minimised the extent of surgery. Combination of surgery and antibiotics is necessary to prevent the development contractures.

摘要

背景

溃疡分枝杆菌病会导致组织广泛破坏,在身体上留下大的溃疡。过去采用手术切除病灶的治疗方法正逐渐被化疗所取代。

目的

研究利福平与链霉素预先治疗溃疡分枝杆菌病对手术的影响。

研究设计

回顾性研究,时间跨度为2004年9月至2009年9月。

研究地点

加纳的阿苏纳福、阿曼西西部、阿哈福阿诺和阿曼西中部地区。

方法

选择已完成8周或至少4周利福平和链霉素治疗但病灶未愈合的患者进行手术。

结果

132例患者接受了溃疡分枝杆菌病手术治疗;51例在特帕(阿哈福阿诺);36例在阿格罗耶苏姆(阿曼西西部);16例来自雅各布(阿曼西中部);29例来自戈阿索(阿苏纳福)地区。他们的年龄在4至98岁之间,平均年龄为29.90岁,标准差为20.74。受累部位包括:头颈部1例(0.74%),上肢40例(29.63%),下肢92例(68.15%),躯干2例(1.48%)(n = 135)。临床类型包括:丘疹1例(0.74%),结节2例(1.48%),水肿性病变4例(2.96%),骨髓炎2例(1.48%),溃疡124例(91.85%),挛缩2例(1.48%)。共进行了139例手术:切除25例(18.11%),植皮36例(26.1%),切除加植皮54例(39.1%),清创术10例(7.2%),死骨切除术2例(1.4%),再次植皮10例(7.2%),挛缩松解术2例(1.4%)。

结论

利福平和链霉素治疗溃疡分枝杆菌病改善了病情并减少了手术范围。手术与抗生素联合使用对于预防挛缩的发生是必要的。

相似文献

1
Surgical management of buruli ulcer disease: a four-year experience from four endemic districts in ghana.布氏杆菌溃疡病的外科治疗:来自加纳四个流行地区的四年经验。
Ghana Med J. 2011 Mar;45(1):4-9. doi: 10.4314/gmj.v45i1.68914.
2
Mycobacterium ulcerans disease in the middle belt of Ghana: An eight-year review from six endemic districts.加纳中部地区的溃疡分枝杆菌病:来自六个流行地区的八年回顾
Int J Mycobacteriol. 2015 Jun;4(2):138-42. doi: 10.1016/j.ijmyco.2015.03.006. Epub 2015 Apr 18.
3
Management of complications of Mycobacterium ulcerans disease: A three-year review.溃疡分枝杆菌病并发症的管理:三年回顾
Int J Mycobacteriol. 2013 Dec;2(4):206-10. doi: 10.1016/j.ijmyco.2013.08.003. Epub 2013 Sep 17.
4
Outcome of Streptomycin-Rifampicin treatment of Buruli Ulcer in two Ghanaian districts.加纳两个地区采用链霉素-利福平治疗布鲁里溃疡的结果
Pan Afr Med J. 2016 Oct 1;25(Suppl 1):13. doi: 10.11604/pamj.supp.2016.25.1.6203. eCollection 2016.
5
Laboratory confirmation of Buruli ulcer cases in Ghana, 2008-2016.加纳 2008-2016 年布鲁里溃疡病例的实验室确认。
PLoS Negl Trop Dis. 2018 Jun 5;12(6):e0006560. doi: 10.1371/journal.pntd.0006560. eCollection 2018 Jun.
6
Buruli ulcer disease.布氏杆菌溃疡病
Ghana Med J. 2011 Mar;45(1):1.
7
Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).对疑似患有大溃疡性病变(溃疡分枝杆菌病)的前瞻性队列患者的治疗反应。
PLoS Negl Trop Dis. 2010 Jul 6;4(7):e736. doi: 10.1371/journal.pntd.0000736.
8
[Present status of Buruli ulcer in Ghana, West Africa].[西非加纳布鲁里溃疡的现状]
Nihon Hansenbyo Gakkai Zasshi. 1999 Nov;68(3):175-84. doi: 10.5025/hansen.68.175.
9
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.早期、局限性溃疡分枝杆菌感染的抗菌治疗:一项随机对照试验。
Lancet. 2010 Feb 20;375(9715):664-72. doi: 10.1016/S0140-6736(09)61962-0. Epub 2010 Feb 3.
10
Providing insight into the incubation period of Mycobacterium ulcerans disease: two case reports.深入了解溃疡分枝杆菌病的潜伏期:两例病例报告
J Med Case Rep. 2019 Jul 18;13(1):218. doi: 10.1186/s13256-019-2144-2.

引用本文的文献

1
Ulcer: Current Trends in Antimicrobial Management and Reconstructive Surgical Strategies.溃疡:抗菌管理与重建手术策略的当前趋势
Life (Basel). 2025 Jul 13;15(7):1096. doi: 10.3390/life15071096.
2
Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa.布鲁里溃疡治疗:西非不同治疗中心的手术干预率差异很大。
PLoS Negl Trop Dis. 2019 Oct 28;13(10):e0007866. doi: 10.1371/journal.pntd.0007866. eCollection 2019 Oct.
3
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).治疗布鲁里溃疡(溃疡分枝杆菌病)的药物。
Cochrane Database Syst Rev. 2018 Aug 23;8(8):CD012118. doi: 10.1002/14651858.CD012118.pub2.
4
Environmental and Behavioral Drivers of Buruli Ulcer Disease in Selected Communities Along the Densu River Basin of Ghana: A Case-Control Study.加纳登苏河流域部分社区布鲁里溃疡病的环境和行为驱动因素:一项病例对照研究
Am J Trop Med Hyg. 2017 May;96(5):1076-1083. doi: 10.4269/ajtmh.16-0749.
5
Immunohistochemical monitoring of wound healing in antibiotic treated Buruli ulcer patients.抗生素治疗的伯里溃疡患者伤口愈合的免疫组织化学监测。
PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2809. doi: 10.1371/journal.pntd.0002809. eCollection 2014 Apr.
6
Burden of Mycobacterium ulcerans disease (Buruli ulcer) and the underreporting ratio in the territory of Songololo, Democratic Republic of Congo.刚果民主共和国松戈洛地区溃疡分枝杆菌病(布氏溃疡)的负担及漏报率
PLoS Negl Trop Dis. 2013 Dec 5;7(12):e2563. doi: 10.1371/journal.pntd.0002563. eCollection 2013.
7
Geographic distribution, age pattern and sites of lesions in a cohort of Buruli ulcer patients from the Mapé Basin of Cameroon.喀麦隆马帕盆地布鲁里溃疡患者队列的地理分布、年龄模式和病变部位。
PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2252. doi: 10.1371/journal.pntd.0002252. Print 2013.
8
Buruli ulcer disease.布氏杆菌溃疡病
Ghana Med J. 2011 Mar;45(1):1.

本文引用的文献

1
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.早期、局限性溃疡分枝杆菌感染的抗菌治疗:一项随机对照试验。
Lancet. 2010 Feb 20;375(9715):664-72. doi: 10.1016/S0140-6736(09)61962-0. Epub 2010 Feb 3.
2
Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease).链霉素-利福平联合用药治疗布鲁里溃疡(溃疡分枝杆菌病)具有良好的临床疗效。
Antimicrob Agents Chemother. 2007 Nov;51(11):4029-35. doi: 10.1128/AAC.00175-07. Epub 2007 May 25.
3
Mycobacterium ulcerans infection: control, diagnosis, and treatment.溃疡分枝杆菌感染:控制、诊断与治疗
Lancet Infect Dis. 2006 May;6(5):288-96. doi: 10.1016/S1473-3099(06)70464-9.
4
Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.利福平-链霉素联合用药预防人类布氏溃疡早期病变中溃疡分枝杆菌生长的疗效。
Antimicrob Agents Chemother. 2005 Aug;49(8):3182-6. doi: 10.1128/AAC.49.8.3182-3186.2005.
5
Mycobacterial skin ulcers in Uganda.乌干达的分枝杆菌性皮肤溃疡
Lancet. 1961 Oct 28;2(7209):951-4. doi: 10.1016/s0140-6736(61)90793-0.
6
Buruli ulcer in Ghana: results of a national case search.加纳的布鲁里溃疡:全国病例搜索结果
Emerg Infect Dis. 2002 Feb;8(2):167-70. doi: 10.3201/eid0802.010119.
7
Socioeconomic implications of Buruli ulcer in Ghana: a three-year review.加纳布鲁里溃疡的社会经济影响:三年回顾
Am J Trop Med Hyg. 1998 Dec;59(6):1015-22. doi: 10.4269/ajtmh.1998.59.1015.
8
Emergence of Buruli ulcer disease in the Daloa region of Cote d'Ivoire.科特迪瓦大洛阿地区布鲁里溃疡病的出现。
Am J Trop Med Hyg. 1995 Mar;52(3):219-24. doi: 10.4269/ajtmh.1995.52.219.
9
The use of surgery and local temperature elevation in mycobacterium ulcerans infection.
Aust N Z J Surg. 1972 May;41(4):312-7.
10
Buruli ulcer in Benin.
Lancet. 1990 Nov 3;336(8723):1109-11. doi: 10.1016/0140-6736(90)92581-2.